Uterine Leiomyosarcoma: A Meta-Analysis Of Systemic Therapy Effectiveness

Uterine Leiomyosarcoma: Systemic Therapy Effectiveness Overview Uterine leiomyosarcoma (uLMS) is an aggressive type of mesenchymal tumor linked to a bleak prognosis. The primary treatment for advanced uLMS is systemic chemotherapy, although the most effective regimen remains uncertain. To address this, we conducted an extensive analysis, including both meta-analysis and metaregression, aiming to

Uterine Leiomyosarcoma: A Meta-Analysis Of Systemic Therapy Effectiveness